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Background: Acute invasive fungal rhinosinusitis is a lethal infectious process afflicting immunocompromised
individuals. Knowledge about this disease is still limited due to the scarcity of animal models designed to study the
pathogenesis of this infection. Mast cells are tissue-resident immune cells that participate in a variety of allergic and
inflammatory conditions. Limited attention has been given to the role of mast cells in acute invasive fungal
rhinosinusitis. Therefore, the objectives of this study were to create a rat model of acute invasive fungal rhinosinusitis
based on analyzing the impact of different fungal concentrations on establishing infection, and to observe the changes
of mast cells in rats with this disease.
Methods: Sprague–Dawley rats were divided randomly into four groups, three of which were experimental and received
different concentrations of Aspergillus fumigatus inoculations, and one was a control group (D). The inoculated Aspergillus
fumigatus concentrations were 5 × 107 conidia/ml in group A, 107 conidia/ml in group B, and 106 conidia/ml in group C.
Before fungal inoculation, rats were immunosuppressed using cyclophosphamide and cortisone acetate, and had Merocel
sponges inserted into the right nares. Hematology and histopathology investigations were then performed.
Results: An acute invasive fungal rhinosinusitis rat model was established successfully with an incidence rate of 90% in
group A, 50% in group B and 10% in group C. Aspergillus fumigatus invasion was observed in 20% of the lungs in group
A, but was not seen in the remaining groups. In addition, no fungi invaded the orbital tissue, brains, livers, spleens or
kidneys of any rat. Compared with the control set, the total number of mast cells in the experimental groups was not
significantly increased, but mast cell degranulation, on the other hand, was only found in infected nasal cavities.
Conclusions: This investigation illustrates that various fungal concentrations have different effects on the incidence of
acute invasive fungal rhinosinusitis, and it also demonstrates the feasibility of using this model to study the process of
fungal rhinosinusoidal invasion. In addition, the results suggest that mast cells may play a role in the protection of sinuses
against acute Aspergillus fumigatus infection and in the clearance of established hyphal masses.
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Acute invasive fungal rhinosinusitis (AIFR) is an aggressive
fungal infection with high mortality rates (50%–80%) in im-
munocompromised patients [1,2]. It is characterized by
fungal invasion into the mucosa and submucosal structures
of the nasal cavity or paranasal sinuses with frequent exten-
sion into adjacent structures, including the nasal soft tissue,* Correspondence: 18931107350ab@sina.com
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unless otherwise stated.vasculature, orbit, and cranium [3-5]. Hematological–onco-
logical malignancies, aplastic anemia, uncontrolled dia-
betes mellitus, and acquired immune deficiency syndrome
(AIDS) are the most common predisposing diseases for
AIFR [6-9]. In addition, long-term steroid treatment and
the utilization of chemotherapy agents and immunosup-
pressants, which are used after bone marrow and solid
organ transplantations, are important risk factors [10-12].
At present, animal models designed for the study of si-
nusitis are limited to bacteria [13-17]. For fungal infec-
tions, most studies focus on pulmonary aspergillosis andis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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senting an AIFR animal model are currently published
[5,24]. Due to the lack of an established AIFR animal
model that closely mimics the pathophysiology of infection
in addition to providing ease of operation, most AIFR re-
search has been limited to clinical observations [2,3,12,25].
Mast cells (MCs) are leukocytes that are derived from
haematopoietic progenitor cells. They are long-lived and
reside in most tissues of the body, particularly in locations
that are in close contact with the external environment,
such as skin, airways, and intestines, where they can initi-
ate and enhance early responses to environmental threats,
including pathogens [26]. MCs are preferentially located
in the vicinity of blood vessels, nerves, and lymphatic ves-
sels, where they can regulate vascular permeability and in-
stigate effector cell recruitment by releasing preformed as
well as de novo synthesized mediators [27]. MCs are also
important effector cells in allergic diseases and protective
immune responses against pathogens, with roles in both
innate and adaptive immunity, including the direct killing
of organisms [28-32]. Because the majority of MC re-
search focuses on bacteria, the role of MCs in the patho-
genesis of fungal infections is poorly understood. A single
in vitro study found that Aspergillus fumigatus hyphae
induced degranulation of MCs via an IgE independent
mechanism [33]. In normal subjects and those with non-
allergic rhinitis, there are few MCs in the epithelial com-
partment of the nasal mucosa. Studies have found that the
number of MCs increases in allergic rhinitis and nasal
polyps [34-36]. Currently, it is still unclear what types of
changes are occurring in the MC population in AIFR.
The focus of our study was to create a novel AIFR rat
model by analyzing the impact of different fungal con-
centrations on AIFR establishment, and then to use this
model to explore the role that MCs may play in the dis-
ease process. In order to develop a novel animal model
of AIFR that is stable and clinically relevant, we tested
numerous immunosuppression regimens and various
concentrations of fungal spores. The intranasal infection
model reported here illustrates that various concentra-
tions of fungi have different effects on AIFR incidence.
With the appropriate concentration of fungi, an AIFR
model that is stable and clinically relevant can be estab-
lished in the immunosuppressed rat, and this model canTable 1 Groups and interventions
Group n Intervention
A 10 Administration of immune inhibitors with nas
B 10 Administration of immune inhibitors with nas
C 10 Administration of immune inhibitors with nas
D 10 No treatment (negative control)




Forty female Sprague–Dawley (SD) rats aged 6–8 weeks
and weighing 230 ± 10 g were used. They were housed in
pathogen-free conditions in the Animal Laboratory of the
First Affiliated Hospital of General Hospital of Chinese
People's Liberation Army (PLA) of Beijing, and the rats
were given food and water at all times. All procedures and
animal care were conducted in accordance with guidelines
set forth by the Institutional Animal Care & Use Commit-
tee (IACUC) of First Hospital Affiliated to PLA General
Hospital and adhere to Reporting In Vivo Experiments
(ARRIVE) guidelines (http://www.nc3rs.org.uk/page.asp?
id=1357). The animal study was approved by the Institu-
tional Animal Care & Use Committee (IACUC) of First
Hospital Affiliated to PLA General Hospital.
Rats were randomly divided into four groups of 10.
Table 1 shows the interventions for each group. The
model was established in three consecutive steps: 1)
Cyclophosphamide (CPA) and cortisone acetate (CA) were
administered, 2) Unilateral nasal cavities were obstructed
with Merocel sponges (Medtronic Xomed, Jacksonville,
FL), and 3) Nasal cavities were inoculated with A. fumiga-
tus. The different experimental groups were inoculated
with various concentrations of A. fumigatus: group A
received 5 × 107 conidia/ml, group B 1 × 107 conidia/ml,
and group C 1 × 106 conidia/ml. Group D was the control
group and received no treatment.
Immunosuppression
Based on many preliminary experiments, we chose cy-
clophosphamide (Sigma, America) [37,38] and cortisone
acetate suspension (Sigma, America) [39-41] as immune
inhibitors to establish immunosuppressed rats before nasal
obstruction and fungal inoculation.
Table 2 shows the doses, timing and methods of cyclo-
phosphamide and cortisone acetate delivery. Five days
before the first administration of A. fumigatus (D-5), rats
in groups A, B and C were given an intraperitoneal in-
jection (ip) of CPA at a dose of 75 mg/kg and a subcuta-
neous injection (sc) of CA at a dose of 80 mg/kg. Oneal obstruction and fungal inoculation of 5 × 107 conidia/ml concentration
al obstruction and fungal inoculation of 107 conidia/ml concentration
al obstruction and fungal inoculation of 106 conidia/ml concentration
Table 2 Rat immunosuppressant doses (mg/kg)
Immunosuppressant D-5 D-1 D + 2
CPA (ip) 75 60 50
CA (sc) 80 80 80
CPA: Cyclophosphamide; CA: Cortisone acetate; D-5: Five days before the first
administration of A. fumigatus spores; D-1: One day before the first administration
of A. fumigatus spores; D + 2: Two days after the first administration of
A. fumigatus spores; ip: Intraperitoneal injection; sc: Subcutaneous injection.
Figure 1 Insertion of Merocel sponge into right nasal cavity of
rat. Merocel sponges were gently inserted 1.5 cm deep into the
rats’ right nasal cavities.
Figure 2 Dropping A. fumigatus spore suspension into right
nasal cavity of rat. With the rats’ nostrils pointed upward,
suspensions of A. fumigatus spores were dropped at a slow speed
into the right nasal cavities.
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rats in groups A through C were given a CPA ip at a
dose of 60 mg/kg and a CA sc at a dose of 80 mg/kg.
The last injections of CPA at a dose of 50 mg/kg and
CA at a dose of 80 mg/kg were given two days after the
first administration of A. fumigatus (D + 2).
For the neutrophil count analysis, whole blood sam-
ples (0.1 ml) were collected from the angular veins of all
rats on D-5, the first administration day of A. fumigatus
spores (D0), and the fourth day after the first adminis-
tration of A. fumigatus (D + 4). The blood counts were
analyzed with SYSMEX XS-820 (Japan) in the Labora-
tory of Beijing Tongren Hospital.
Fungi inoculum
A. fumigatus strain (AF9732 wild strain from the Fungi
and Fungal Disease Research Center of Peking University)
was grown on potato dextrose agar (PDA) plates at 37°C
for 5 days. Conidia were harvested by washing the plates
with sterile 0.2% Tween 20, followed by centrifugation and
filtration of the suspension through eight layers of sterile
gauze to remove hyphae. The conidia were subsequently
diluted and counted with a hemocytometer to obtain 5 ×
107, 1 × 107 and 1 × 106 conidia/ml suspensions.
Nasal obstruction and intranasal inoculation of A.
Fumigatus conidia
On the second day after the second injection of CPA
and CA, rats in experimental groups were anesthetized
with intraperitoneal injections of 3% pentobarbital so-
dium (Sigma, America) at 40 mg/kg. A piece of Merocel
sponge was inserted 1.5 cm deep into the right nasal
cavity of each experimental rat (Figure 1). Then a sus-
pension of 100 μl of A. fumigatus conidia was dropped
into the right nasal cavity, with a concentration of 5 ×
107 conidia/ml in group A, 1 × 107 conidia/ml in group
B, and 1 × 106 conidia/ml in group C (Figure 2). These
fungal inoculations were performed for three consecu-
tive days.
Histopathology analysis
Rats were euthanized with a respiratory-failure dose of
120 mg/kg of pentobarbital sodium (Sigma, America)
given by intraperitoneal injection four days after the first
administration of A. fumigatus conidia. The rats werethen decapitated. The skin on the heads was divested and
the mandibles were removed. The specimens were soaked
in 10% neutral paraformaldehyde for 24 hours. This
was followed by decalcification with decalcifying fluid
(0.5 mol/L ethylenediaminetetraacetic acid (EDTA), PH
7.4) for one month until soft. The heads were subse-
quently cut coronally for 2 mm and made into wax blocks,
sectioned at 3 μm thickness, and stained with hematoxylin
and eosin (HE), Periodic acid-Schiff (PAS), methenamine
silver and MUC5B for visualization of the fungi.
Lungs, livers, kidneys and spleens were also extracted
for histopathological examination with HE staining.
Toluidine blue staining
To assist in differentiating MCs from other inflamma-
tory cells, toluidine blue staining was used in this study.
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drated, and stained with 0.5% toluidine blue. These sec-
tions were stored at 4°C for one night, and subsequently
underwent glacial acetic acid differentiation and vitrifica-
tion by dimethylbenzene. MCs were identified by deep
blue staining.
Immunohistochemical staining for mast cells
Immunohistochemistry was performed using the horse-
radish peroxidase (HRP) immunohistochemical method.
Tissue sections (3 μm) were deparaffinized and rehydrated
in distilled water. Endogenous peroxidase activity was
blocked by incubation with 0.3% hydrogen peroxide for
10 minutes at room temperature. Antigen retrieval was per-
formed by cooking the sections in citrate solution for 2–3
minutes. The tissue sections were then incubated with anti-
mast cell tryptase antibody (AA1IgG1; 1:2000 dilutions) for
35 minutes in a 37°C water bath box after being rinsed once
with distilled water and three times with phosphate buffers
(PBS) (pH 7.4). The slides were again rinsed with distilled
water and PBS (pH 7.4), and exposed to Polymer Helper
(direct use type) for 20 minutes in a 37°C water bath box.
After washing with distilled water and PBS (pH 7.4) a third
time, the slides were exposed to Poly-HRP anti-Mouse IgG
(direct use type, no cross reaction with rats) for 20 minutes
in a 37°C water bath box. They were then washed a final
time in distilled water and PBS (pH 7.4) before diamino-
benzidine (DAB) coloration. Lastly, the slides were counter-
stained with hematoxylin after rinsing with water. MCs
were identified by dark-brown staining.
Statistics
Statistical analyses were performed using SPSS 17.0 (SPSS,
Inc., America, English). Comparisons across interventions
were evaluated using Chi-square test and repeated mea-
sures analysis of variance (REP ANOVA). P-values less
than 0.05 were considered to be statistically significant.
Results
The rats were diagnosed with AIFR if histopathology re-
vealed the presence of A. fumigatus hyphae within nasal
tissue. During the entire length of the experiment, the
Merocel sponges demonstrated no prolapse by remaining
in the nostrils of all rats.Table 3 Rat weight changes (g) by group
Group n D-5 D-1 D0
A 10 237.0 ± 14.58 226.9 ± 8.76 220.4
B 10 242.4 ± 12.60 236.6 ± 11.34 224.0
C 10 241.3 ± 2.43 233.0 ± 9.26 222.1
D 10 237.0 ± 9.78 239.7 ± 8.12 241.0
n: Number of rats; D-5: Five days before the first administration of A. fumigatus spo
first administration day of A. fumigatus spores; D + 2: Two days after the first admin
D + 3: Three days after the first administration of A. fumigatus spores; D + 4: Four daGeneral observations
All experimental rats (groups A, B and C) had decreased
appetite after immune inhibitor injection and fungal in-
oculation, and exhibited lethargy with dulling of their fur.
On the second day after the first fungal inoculation, sneez-
ing and nose scratching were observed in each group.
Table 3 and Figure 3 illustrate the changes in rat weights
throughout the experiment. Groups A, B and C, which
were immunosuppressed and inoculated with A. fumigatus,
had a gradual decline in average weight (P < 0.05), but no
significant differences in body weight changes were found
between the three groups (P > 0.05). Weights in group D
had an increasing trend throughout the entire experiment
(P < 0.05).
Absolute neutrophil count
For groups A, B and C, the neutrophil quantities on D0
were less than 0.1 × 109/L, which were lower than the
neutrophil counts for group D ((3.7 ± 1.84) × 109/L).
Histopathological examination
AIFR affected 90% (9/10) of the rats in group A, 50%
(5/10) in group B, and 10% (1/10) in group C (Figure 4).
The fungal infection rate of group A was significantly
higher than that of group B (P > 0.05) and group C (P <
0.05). Only one case of AIFR was established in group C,
which had an infection rate that was significantly lower
than that of group A (P < 0.05) but not group B (P > 0.05).
No AIFR was found in group D.
According to our study, the rat nasal septum was the
most susceptible site to A. fumigatus hyphae, followed
by the turbinate, ethmoidal sinus and maxillary sinus
(Figure 5). The AIFR rats in group A had a heavy A.
fumigatus hyphal invasion. The nasal and sinus mucosa
contained a large number of fungal components (Figure 5),
which caused fungal vasculitis (Figure 6), vascular embol-
ism, hemorrhage, and coagulative necrosis. Simultaneously,
bone resorption (caused by the direct intrusion of hyphal
masses) was observed without obvious infiltration of in-
flammatory cells or osteoclast cells near extremely necrotic
tissue (Figure 5A, B, C). The hyphae were shaped like ant-
lers, which is a morphological feature of A. fumigatus. Large
numbers of fungal components and pyogenic granulomas
were also seen in the pulmonary tissue of two rats in groupD + 2 D + 3 D + 4
± 8.90 207.9 ± 19.50 199.7 ± 16.70 199.2 ± 23.11
± 10.17 211.1 ± 9.82 203.4 ± 7.23 199.0 ± 11.62
± 8.75 213.6 ± 12.00 201.3 ± 12.50 197.9 ± 14.10
± 7.75 243.3 ± 6.92 243.6 ± 6.55 244.4 ± 6.43
res; D-1: One day before the first administration of A. fumigatus spores; D0: The
istration of A. fumigatus spores;
ys after the first administration of A. fumigatus spores.
Figure 3 Changes of rat weight by group (g). In groups A, B and C,
rat weight showed a trend downward after injecting CPA and CA and
inoculation of A. fumigatus. In group D, rat weight showed a gradually
increasing trend during the experiment. (D-5: Five days before the first
administration of A. fumigatus spores; D-1: One day before the first
administration of A. fumigatus spores; D0: The first administration day of
A. fumigatus spores; D + 2: Two days after the first administration of
A. fumigatus spores; D + 3: Three days after the first administration of A.
fumigatus spores; D + 4: Four days after the first administration of A.
fumigatus spores).
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found in group B. In addition, only a few invading A.
fumigatus hyphae were seen in one of the rats belonging
to group C. No lung was infected by A. fumigatus in
groups B or C, and invasion was not found in the brain,
liver, kidney or spleen of any group.Figure 4 Rates of acute invasive fungal rhinosinusitis (AIFR) in
each group. Rats in group A had the highest AIFR incidence,
followed by rats in groups B and C. No rat in group D was infected
by A. fumigatus.Different degrees of epithelial hyperplasia, disorder,
and loss, in addition to gland hypertrophy, were found
in all the experimental rats. No animal died prior to the
euthanization stage.Observation of mast cells in AIFR
MCs were identified by both metachromatic staining with
toluidine blue and immunohistochemical staining for tryp-
tase. Using toluidine blue, MCs were identified in tissue
sections by their characteristic granular, deep blue-purple
metachromatic appearance against blue orthochromatic
background tissue (Figure 8). With the tryptase immuno-
histochemical stain, MCs were identified by dark-brown
staining (Figure 9). Compared with the normal nasal cavity
(Figure 10), the total number of MCs in A. fumigatus
invasion areas was not increased. MC degranulation, on
the other hand, was only found in or around regions of
fungal invasion. While connective tissue around rat noses
showed more MC infiltration than nasal cavities, no de-
granulation was observed in such areas (Figure 11).Discussion
We successfully established an AIFR rat model that was
stable and easy to operate by utilizing the administration
of CPA and CA with subsequent nasal obstruction and
fungal inoculation, which allowed us to research MC re-
sponse to AIFR. This model is based on the develop-
ment of rat models for bacterial rhinosinusitis and
invasive pulmonary aspergillosis [13-17,19,20,22,23]. Ac-
cording to the clinical diagnosis of AIFR, we used the
following categories to determine whether the model
was successful: general response, immune status, and
histopathological examination.
In our study, rats in group A, which were inoculated
with 5 × 107 conidia/ml of A. fumigatus, had the highest
AIFR incidence (90%), followed by rats in group B (50%)
and group C (10%). No AIFR occurred in group D. Also,
several infiltrating and degranulating MCs were found in
regions infected with A. fumigatus hyphae. These results
indicate that A. fumigatus concentration played an import-
ant role in the occurrence and development of AIFR, and
MCs may have an effect on this disease process.
In our study, we chose SD rats, which were bred with
Wistar rats, as the experimental animal, because they
are more genetically stable than Wistar. Compared with
rabbits and other large animals, rats are less expensive
and easier to handle. In addition, they have more blood
volume than mice, which is necessary for the repeated
sampling of large quantities of blood in this study. Also,
based on our pre-experiments, it was difficult to insert
Merocel sponges into mouse nasal cavities, and ins-
tillation of A. fumigatus into mice without previously
Figure 5 A. fumigatus hyphae invasion in sinus cavity mucosa of rat with acute invasive fungal rhinosinusitis (AIFR). Bone resorption is caused
by the intrusion of hyphal masses. The hyphae are antler-like. (A1. Hematoxylin and eosin staining, ×20; A2. Hematoxylin and eosin staining, ×40; B1.
Periodic acid–Schiff staining, ×10; B2. Periodic acid–Schiff staining, ×40; C. Methenamine silver staining, ×40; D. MUC5B staining, ×40).
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more frequently than AIFR.
Because AIFR occurs mainly in immunodeficient pa-
tients, we chose to first immunosuppress rats in order to
simulate clinical AIFR. Our immunosuppression procedureFigure 6 Vascular invasion of A. fumigatus hyphae in sinus of rat with
eosin staining, ×40; B. Periodic acid–Schiff staining, ×40; C. Methenamine swas based on utilizing CPA in combination with CA. The
selection of dosage for CPA and CA was based on a large
number of pre-experiments in addition to the results of
various articles researching invasive pulmonary aspergillosis
in rats [37-41]. CPA is an alkylating agent from theacute invasive fungal rhinosinusitis (AIFR). (A. Hematoxylin and
ilver staining, ×40; D. MUC5B staining, ×40).
Figure 7 Abundant A. fumigatus hyphae in lung tissue of group A. (A1. Hematoxylin and eosin staining, ×10; A2. Hematoxylin and eosin
staining, ×40; B1. Periodic acid–Schiff staining, ×10; B2. Periodic acid–Schiff staining, ×40; C1. Methenamine silver staining, ×10; C2. Methenamine
silver staining, ×40).
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widely used in clinical practice [42]. Unfortunately, CPA in-
take is associated with many serious side effects and tox-
icity, including mutagenicity, myelosuppression, cardiac
toxicity, lung toxicity and urotoxicity, which are mainly me-
diated by reactive oxygen species and lipid peroxide forma-
tion [43,44]. In our preliminary studies, large doses of CPA
induced hematuria in rats, and the mortality rate was high.Figure 8 A. Mast cell (MC) degranulation in hyperplastic mucosa of ra
staining, ×40). B. Mast cell (MC) degranulation in rat nasal septum invade
MC degranulation. Black arrow indicates A. fumigatus hyphae.CA is a type of adrenal cortical hormone with immunosup-
pressive effects, which can aggravate fungal infections. By
adding CA to our immunosuppression procedure, we were
able to reduce the dosage of CPA and, thus, rat mortality,
which improved the success rate of establishing an AIFR
rat model. Several papers have reported that an invasive
pulmonary aspergillosis (IPA) rat model can be established
under neutropenic conditions (<0.1 × 109/L on the day oft maxillary sinus invaded by A. fumigatus (Toluidine blue
d by A. fumigatus (Toluidine blue staining, ×40). Red arrow indicates
Figure 9 Tryptase immunohistochemical staining for mast cell (MC) infiltration and degranulation in rat nasal mucosa invaded by
A. fumigatus. Both tryptase-positive MCs and tryptase-positive granules are stained dark brown. (Original magnification × 40 in A, ×20 in C, and ×
100 in B and D). Red arrow indicates MC infiltration and degranulation. Black arrow indicates A. fumigatus hyphae.
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counts on D0 were also less than 0.1 × 109/L. After im-
munosuppression, all experimental rats demonstrated de-
creased energy and appetite, in addition to dulling of the
fur and weight lost. Under these immunosuppressive condi-
tions, we were able to successfully establish an AIFR rat
model with no rat mortality.
In humans, ostiomeatal obstruction is a key precipitat-
ing factor in the pathogenesis of sinusitis. ObstructingFigure 10 Mast cell (MC) infiltration in normal rat turbinate of group
staining for MC infiltration, ×20).the ventilation and drainage of the nasal cavity and sinus
is one of the major virulence factors of fungal sinusitis.
Clinically, the Merocel sponge is often used for patients
with epistaxis or after nasal surgery. It has good tissue
compatibility and rarely damages the nasal mucosa.
Also, it is easy to insert into the nasal cavity and is diffi-
cult to prolapse. In 2008, a rabbit model of chronic rhi-
nosinusitis was developed using Merocel sponges, which
demonstrated that the Merocel sponge can remain inD. (A. Toluidine blue staining, ×20; B. Tryptase immunohistochemical
Figure 11 More mast cell (MC) infiltration in rat nasal peripheral connective tissue in all groups. No MC degranulation was found.
(A. Toluidine blue staining, ×20; B. Tryptase immunohistochemical staining for MC infiltration, ×20).
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Jin et al. reported that bacteria can cause rhinosinusitis
under the condition of nasal obstruction with Merocel
sponges, while bacteria alone cannot induce rhinosinusitis
[15]. Nasal obstruction by Merocel sponges closely mimics
the natural course of anthropic invasive fungal rhinosi-
nusitis (IFRS) without surgical damage to local bone or
mucosal integrity [24]. These reasons, along with its ease
of manipulation, support the use of Merocel sponges in
rhinosinusitis studies.
Aspergillus is one of the main pathogens found in
patients with AIFR [3,46]. There are almost 900 species
of Aspergillus in nature, and A. fumigatus is the most
common one in humans [12]. These organisms are
normally found in dust, soil, and the upper respiratory
mucosa of healthy individuals. Generally, in healthy
individuals, these spores are quickly eliminated by the
immune system. However, in immunocompromised pa-
tients, inhalation of A. fumigatus may lead to AIFR.
Based on a large number of pre-experiments, various
concentrations of fungal conidia have different effects on
the rat sinus. An A. fumigatus concentration of 1 × 108
conidia/ml caused a high mortality rate (>50%). Conse-
quently, we chose 5 × 107, 1 × 107 and 1 × 106 conidia/ml
concentrations of A. fumigatus as the spore suspensions
for this study, and we subsequently compared their dif-
ferent effects on establishing an AIFR rat model.
At present, only two papers reporting on an AIFR ani-
mal model have been published. In 2007, Rodriguez et al.
developed a mouse model of AIFR through depleting neu-
trophils using anti-Gr-1 monoclonal antibody combined
with the intranasal administration of A. fumigatus [5]. In
this experiment, they failed to successfully utilize CPA in
developing their animal model, which may be related to
an inappropriate dose of cyclophosphamide. In contrast to
this study, we immunosuppressed experimental rats by
using CPA and CA, which are easily obtainable, com-
monly used immune inhibitors in the clinic. In 2013, agroup of researchers established a rat model of AIFR [24].
They obstructed the rat nasal cavity with Merocel sponges
for 5 days, and then injected CPA for immunosuppression,
followed by inoculating A. fumigatus for a week. The entire
experiment lasted for 18 days. In contrast, we developed a
novel method to establish an AIFR rat model that better
simulates the disease process in humans. In order to mimic
the clinical process of AIFR formation, we injected rats with
immune inhibitors first, and then inserted Merocel sponges
into the rats’ nasal cavities, followed by inoculating A.
fumigatus for three days. The entire experimental process
lasted for only nine days. Compared with the two published
studies, our methods are easier to operate and provided a
stable fungal infection rate.
MCs, which play key roles in innate and adaptive
immunity, are important effector cells in protective
immune responses against pathogens [28-32]. While in-
creasingly more data indicate that MCs play a crucial
role in host defense, especially against bacteria [29], very
little is known about the relevance of MC effects in fun-
gal infections. In addition, no study has reported on the
role of MCs in AIFR. Here, we observed the changes of
MCs in AIFR rats. Toluidine blue, which is reliable in
identifying MCs, and immunohistochemical staining for
tryptase, which is a highly sensitive and specific method
for MC identification [47], were used in this study. We
observed that the total number of MCs in A. fumigatus
invasion areas were not increased compared to normal
rat nasal cavities. Even with low quantities, MC degranu-
lation was found only in regions of A. fumigatus invasion
or nearby perivascular areas. This indicates that the
main role of MCs may not consist of direct phagocytosis
after migration to fungal infection zones in AIFR, but
instead may involve degranulation or the release of
cytokines and chemokines involved in innate and adap-
tive immunity. Several researchers have reported that
the functional status of MCs is represented by MC
degranulation, and the ability of MCs to degranulate in
Yan et al. BMC Infectious Diseases  (2014) 14:3856 Page 10 of 11response to various stimuli is the very basis for their
biological activity [48]. Through degranulation, MCs
release several classes of preformed mediators, including
histamine and proteases, contributing to host defense. In
addition, MCs also employ numerous de novo synthe-
sized mediators, many of which have been shown to be
involved in protective host responses to fungal patho-
gens, such as IFN-γ [49].
Conclusions
Various fungal concentrations have different effects on
establishing an AIFR rat model. The optimal fungal con-
centration plays an important role in the course of forma-
tion and development of AIFR. By inoculating a suspension
of 5 × 107 conidia/ml, a stable AIFR rat model that is easy
to operate can be established successfully. The MC data of
the present study indicate that MCs may mainly play a role
through degranulation or the release of cytokines and
chemokines involved in innate and adaptive immunity,
instead of direct phagocytosis of fungi in AIFR. The immu-
noregulatory role of MCs in both protective and destructive
AIFR immune responses should be further evaluated, and
detailed studies of MC function will enable the develop-
ment of more effective therapies for AIFR via MC manipu-
lation. Our AIFR rat model can be used to study the nasal
immune mechanisms against A. fumigatus, and may be
useful for the research of AIFR and MCs in the future.
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